These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 9582559

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MPO-ANCA-associated pulmonary-renal vasculitis in a patient with diabetes mellitus.
    Keven K, Akar H, Kutlay S, Nergizoglu G, Erbay B, Erturk S.
    J Nephrol; 2002; 15(6):720-3. PubMed ID: 12495292
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ANCA-positive crescentic glomerulonephritis in chronic bronchiectasis.
    McKane WS, Velasco N, Farrington K.
    Nephrol Dial Transplant; 1995; 10(8):1447-50. PubMed ID: 8538942
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Rapidly progressive glomerulonephritis: current and evolving treatment strategies.
    Little MA, Pusey CD.
    J Nephrol; 2004; 17 Suppl 8():S10-9. PubMed ID: 15599880
    [Abstract] [Full Text] [Related]

  • 16. Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan.
    Muso E, Ito-Ihara T, Ono T, Imai E, Yamagata K, Akamatsu A, Suzuki K.
    Jpn J Infect Dis; 2004 Oct; 57(5):S17-8. PubMed ID: 15507757
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution.
    Souid M, Terki NH, Nochy D, Hillion D.
    Clin Nephrol; 2001 Apr; 55(4):337-8. PubMed ID: 11334325
    [No Abstract] [Full Text] [Related]

  • 19. Clinicopathological study of myeloperoxidase anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Yorioka N, Taniguchi Y, Amimoto D, Ogata S, Sakikubo E, Yamakido M, Naito T, Shimamoto F.
    Clin Nephrol; 1999 Nov; 52(5):293-6. PubMed ID: 10584992
    [Abstract] [Full Text] [Related]

  • 20. Plasmapheresis with immunosuppressive therapy vs immunosuppressive therapy alone for rapidly progressive anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis.
    Nakamura T, Matsuda T, Kawagoe Y, Ueda Y, Ebihara I, Koide H.
    Nephrol Dial Transplant; 2004 Jul; 19(7):1935-7. PubMed ID: 15199209
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.